PACTR201901529431463已完成4 期
Evaluation of the Efficacy and Safety of Sublingual Immunotherapy ( Traditional Coca’s extract) in the treatment of Allergic Rhinoconjunctivitis
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 13 Year(s) 至 18 Year(s)（—）
- 性别
- All
入选标准
- •Adolescent or adult Patient with a history of moderate to severe chronic allergic rhinoconjunctivitis without any co-morbidities.
排除标准
- •The study excluded any patient with active, acute, or chronic obstructive pulmonary disease, except for asthma and allergic rhinitis; forced expiratory volume in 1 s = 70% of predicted value;
- •Patients who have disorders concerning drug absorption, distribution, metabolism, and excretion.
- •Inability to perform Skin prick test in patients included in group 2.
- •Illiterate patients who cannot read the self-administered quality of life questioner were also excluded.
- •Refusal of consent.
研究者
相似试验
已完成
不适用
Evaluation of the efficacy and safety of luseogliflozin and changes in QOType 2 diabetes mellitusJPRN-UMIN000023035The Institute for Adult Diseases, Asahi Life Foundation64
已完成
2 期
Squalene for COVID-19 treatmentCOVID-19.COVID-19, virus identifiedU07.1IRCT20200927048848N3Mashhad University of Medical Sciences200
已完成
4 期
The evaluation of the efficacy and safety of oral fingolimod in relapsing remitting multiple sclerosismultiple sclerosis.Disseminated Multiple SclerosisIRCT201406018323N10Vice-chancellor for research, Kermanshah University of Medical Sciences60
已完成
1 期
A trial to evaluate an oral medicinal cannabis extract compared with placebo for the treatment of insomnia.Neurological - Other neurological disordersInsomniaACTRN12618000078257Zelda Therapeutics Limited24
已完成
2 期
Sublingual immunotherapy with VALERGEN-Asthma-Children-Phase IIAsthmaRPCEC00000125ational Center of Bioproducts (BioCen)300